Skip to content
High Tech Seed Founded 2019

Variational

Variational is a developer of an AI-based platform for small-molecule drug discovery. The companys flagship platform, Enki, represents the first commercially available foundation model designed to generate novel, synthesis-ready drug candidates with optimized properties including potency, selectivity, and ADMET profiles. Variational leverages generative AI to accelerate the drug discovery process, enabling…

📍 Vancouver, Canada · Generative AI,

Funding snapshot

Last roundSeed
Amount$6M
Date20 February 2025
Total raised$9M
Team size23

About

Variational is a developer of an AI-based platform for small-molecule drug discovery. The companys flagship platform, Enki, represents the first commercially available foundation model designed to generate novel, synthesis-ready drug candidates with optimized properties including potency, selectivity, and ADMET profiles. Variational leverages generative AI to accelerate the drug discovery process, enabling pharmaceutical companies to identify and optimize drug candidates more efficiently than traditional methods. The platform supports lead discovery, molecular optimization, and predictive modeling for drug development. Founded in 2019 and headquartered in Vancouver, Canada, Variational has raised approximately 9 million at the Seed stage with 23 employees and investors including Flying Fish Ventures, Alliance of Angels, Merck Global Health Innovation Fund, and Nimbus Synergies.

Business model

Life Sciences Tech > Research & Development > Drug Discovery > Cheminformatics > Lead Discovery > AI Based

Founders & team highlights

Serial Founder

Institutional investors

Flying Fish Ventures Alliance of Angels A&E Investments Nimbus Synergies Merck Global Health Innovation Fund Quimby Investments Threshold Impact Amarjit Gill Lip-Bu Tan Ray Muzyka

Latest coverage

No articles yet.

Raising like Variational?

Analyze your pitch deck before your next raise.

Analyze My Deck →